Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.
about
TNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activationTRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptorGeneration and activation of multiple dimeric transcription factors within the NF-kappaB signaling systemA fourth IkappaB protein within the NF-kappaB signaling moduleAutoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunityCoordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissuesGenetic requirements for the development and differentiation of interleukin-17-producing γδ T cellsp100 Deficiency is insufficient for full activation of the alternative NF-κB pathway: TNF cooperates with p52-RelB in target gene transcriptionNF-kappaB: a multifaceted transcription factor regulated at several levelsBasic principles and emerging concepts in the redox control of transcription factorsNIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activationLupeol is one of active components in the extract of Chrysanthemum indicum Linne that inhibits LMP1-induced NF-κB activationTwo carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell linesDifferential utilization of NF-kappaB RELA and RELB in response to extracellular versus intracellular polyIC stimulation in HT1080 cells.c-IAP1 and c-IAP2 redundancy differs between T and B cells.TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.RelB-dependent stromal cells promote T-cell leukemogenesisDifferential RelA- and RelB-dependent gene transcription in LTbetaR-stimulated mouse embryonic fibroblastsInterleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbetaTRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.Non-canonical NF-κB activation and abnormal B cell accumulation in mice expressing ubiquitin protein ligase-inactive c-IAP2.Roles of the NF-kappaB pathway in lymphocyte development and function.Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor.Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.The MC160 protein expressed by the dermatotropic poxvirus molluscum contagiosum virus prevents tumor necrosis factor alpha-induced NF-kappaB activation via inhibition of I kappa kinase complex formation.Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genes.Circuitry of nuclear factor kappaB signaling.Lymphotoxin β receptor activation promotes bladder cancer in a nuclear factor-κB-dependent manner.A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activityActivation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvantEpstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.NIK is involved in nucleosomal regulation by enhancing histone H3 phosphorylation by IKKalpha.Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP).Regulation of late B cell differentiation by intrinsic IKKalpha-dependent signals.Functions of NF-kappaB1 and NF-kappaB2 in immune cell biologyFbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma.Lymphotoxin and LIGHT signaling pathways and target genes.A role for the IkappaB family member Bcl-3 in the control of central immunologic toleranceInhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1.
P2860
Q24297399-9643022F-61EE-4828-BEA8-C96676FA8AEFQ24300996-C7DA4D42-6EF1-4D9F-BB8F-424ADDBFB3B9Q24641914-336757EF-29C3-4B1F-B202-358B99493AD0Q24676472-3EE1C04C-F98F-4193-9572-000E075E9800Q24684338-42D1126C-0E1F-4462-AF17-2B699E64BB3CQ24685416-C1D9D8AF-DCC6-4919-9654-E7E6B9526227Q27026048-4A89E79A-798A-4B43-829D-C5DA19FF7C1BQ27324491-D8D1029B-7C1E-4750-808C-090148742B71Q28285466-E8121A01-C493-4B62-9149-AA24B5C52A3FQ28391506-B466BC79-3F5E-4EF4-9A46-1391DB7D8398Q28508229-C5E804D5-AD4A-4C50-8F1A-55B3E8ACD7B5Q28535439-27BE2DA5-FB0F-4A18-9E70-EBBDF89BE3CDQ28565703-4F992DAD-A3EB-41C0-9808-48FD33183D09Q30498322-D951F041-16D2-4404-80D1-FE26427BDE61Q31120747-E70893A4-1A59-4EDA-890D-15E333A77452Q31148506-D6017027-F90F-4DD0-AEA7-075696CE7EBBQ33348553-F3E79A83-50AF-4212-B9B1-E2D12BF4A8C2Q33393459-CE45AC0C-0CAF-4955-AC19-25044C6D14A5Q33669288-8F17036A-0118-4852-B79E-AAFDCB8DDD01Q33707599-54A4DA89-6070-48D0-AA8B-4EF792591D66Q33737597-959918D7-5677-442E-91C7-707B8083EAC8Q33800318-1DB0805E-522F-4C1F-9985-80A848DB7E23Q33883378-F28C8B0C-66E0-4260-BE99-B2DB00E3BDBCQ33997736-9D5C654E-B8A5-42DB-A770-2055F6DDD079Q34124144-A99CB0DD-378C-4B71-84B2-83B43A34079EQ34301763-E65A0F2A-0159-4ABF-8544-D5E95AF08E7BQ34330967-8C1A67E5-CEBA-4CA3-ABC1-DD0D468A5874Q34514908-E2FCC9A8-10A0-4534-9B99-9145648A151FQ34673313-FDC61778-8D5F-4605-A5BD-E8EE082B4763Q35048852-3F4BDB34-18AE-4971-983D-A71630ED70F1Q35080697-09D906D4-7132-4AA7-B019-A70E16B1AA05Q35121711-10A7BBB0-0A94-402D-BAE1-7834E2284A1CQ35180326-288CAF4E-0588-4996-B663-1404DAA3D0A7Q35319917-D32DF295-3BD3-4A48-8E30-D7763AFFABDAQ35748742-250C6027-6CF9-4A12-BDF1-22175CA4CE2AQ35815962-95CC2FDC-F08C-4E30-8B43-8A94A78C16DBQ35919057-5BA045CB-F677-4229-993F-9EA4EDFF5C41Q35951798-7C1CDE66-0F6B-4ABD-9C9D-9A485E521EC4Q36025311-425987BF-D68C-4496-9B99-0CDF704C83CEQ36172960-5FFC1239-F05B-4657-90BC-856BEFADE8FA
P2860
Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Lymphotoxin beta receptor indu ...... a separate signaling pathways.
@ast
Lymphotoxin beta receptor indu ...... a separate signaling pathways.
@en
Lymphotoxin beta receptor indu ...... a separate signaling pathways.
@nl
type
label
Lymphotoxin beta receptor indu ...... a separate signaling pathways.
@ast
Lymphotoxin beta receptor indu ...... a separate signaling pathways.
@en
Lymphotoxin beta receptor indu ...... a separate signaling pathways.
@nl
prefLabel
Lymphotoxin beta receptor indu ...... a separate signaling pathways.
@ast
Lymphotoxin beta receptor indu ...... a separate signaling pathways.
@en
Lymphotoxin beta receptor indu ...... a separate signaling pathways.
@nl
P2860
P356
P1476
Lymphotoxin beta receptor indu ...... a separate signaling pathways.
@en
P2093
Jürgen R Müller
Ulrich Siebenlist
P2860
P304
12006-12012
P356
10.1074/JBC.M210768200
P407
P577
2003-01-28T00:00:00Z